HOME >> BIOLOGY >> NEWS
XDx to present recent success with AlloMap molecular expression testing

San Francisco, CA, May 7, 2007 -- XDx, a molecular diagnostics company, today announced its AlloMap molecular expression test will be the subject of presentations and discussions at the American Transplant Congress 2007 held here, May 5 to 9.

The test, currently used to detect the absence of heart transplant rejection instead of routine invasive heart muscle biopsies, has now been shown to correlate with oxygen saturation levels, cardiac filling pressures, and the electrical properties of the transplanted heart. Also, data from the Lung Allograft Rejection Gene expression Observation (LARGO) study presented at the ATC sessions demonstrate that a non-invasive blood test can detect cytomegalovirus-induced immune responses in lung transplant patients.

"These data continue to validate the outcomes of the Cardio Allograft Gene Expression Observational (CARGO) and LARGO studies and demonstrate how non-invasive molecular expression testing can be used clinically," said Mario C. Deng, M.D., director of Cardiac Transplantation Research, Columbia University Medical Center/New York-Presbyterian Hospital, and co-principal investigator in the Cardiac Allograft Gene Expression Observational (CARGO) study. "For the 21,000 U.S. heart transplant patients undergoing an estimated 40,000 heart muscle biopsies each year, a non-invasive test is a welcome alternative."

In separate studies, recent data from the CARGO study show that the non-invasive AlloMap molecular test may help reduce the use of immunosuppressants without the need for invasive biopsies and can serve to measure heart graft blood flow and blood pressure.


'"/>

Contact: Breanne Thomlison
bthomlison@prnewswire.com
646-722-8828
HealthStar PR
7-May-2007


Page: 1

Related biology news :

1. Illinois researchers presenting at ASPB Annual Meeting in Chicago, July 7-11
2. Progenika Biopharma presents a biochip that guarantees safety in blood transfusions
3. 18-year-old Singaporean student to present stem cell research paper at conferences in US and UK
4. WPI professor to represent American Mathematical Society at exhibition on science funding
5. SNM presents awards on Capitol Hill
6. Duetting birds with rhythm present a greater threat
7. ESA presents the sharpest ever satellite map of Earth
8. Clinical trial data regarding NKTR-061 will be presented at ATS International Conference
9. Data presented at ISHLT meeting confirm RNA analysis can identify rejection in lung transplant recip
10. Latest plant health research to be presented in San Diego
11. AACR to present distinguished public service awards at 2007 Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... ... August 12, 2020 , ... ... systems that are ideal for public health agencies of all sizes. With a ... and helping at-risk individuals find appropriate health care, Mosio helps public health departments ...
(Date:7/31/2020)... , ... July 30, 2020 , ... ... (SBIR) Phase II contract awarded by the Joint Science & Technology Office—Chemical and ... project is to develop, optimize, and scale-up a highly efficient mammalian cell culture-based ...
(Date:7/10/2020)... CHURCH, Va. (PRWEB) , ... July 08, 2020 ... ... The Latest on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July ... may need a comparability study, but what is the most effective way to ...
Breaking Biology News(10 mins):
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed ... Manager Regulatory Solutions, in a one hour live webinar on Thursday, August ... in China for drugs and medical devices. Specifically, for medical devices, the NMPA has ...
(Date:7/18/2020)... , ... July 16, 2020 , ... ... to aid in the early detection and prevention of high-burden diseases, and Centric ... US-based hospitals and healthcare organizations to utilize existing data in order to identify ...
(Date:7/10/2020)... ... July 09, 2020 , ... PathSensors Inc., ... has expanded the company’s exclusive license to include clinical applications for CANARY™ ... market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and highly ...
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in ... the patient's condition, treatment may be offered IV, intrathecal or with a combination. , ... dementia, and the incidence continues to increase as individuals live longer. There is no ...
Breaking Biology Technology:
Cached News: